セルソースの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/04/15 | 1,503 | 1,553 | 1,486 | 1,546 | +73 | +5% | 155,500 |
| 2024/04/12 | 1,477 | 1,510 | 1,465 | 1,473 | +5 | +0.3% | 96,100 |
| 2024/04/11 | 1,440 | 1,478 | 1,431 | 1,468 | +22 | +1.5% | 83,200 |
| 2024/04/10 | 1,498 | 1,507 | 1,445 | 1,446 | -59 | -3.9% | 180,700 |
| 2024/04/09 | 1,509 | 1,544 | 1,493 | 1,505 | +18 | +1.2% | 140,600 |
| 2024/04/08 | 1,467 | 1,527 | 1,449 | 1,487 | +39 | +2.7% | 172,300 |
| 2024/04/05 | 1,435 | 1,458 | 1,418 | 1,448 | +8 | +0.6% | 131,700 |
| 2024/04/04 | 1,425 | 1,458 | 1,407 | 1,440 | +26 | +1.8% | 141,500 |
| 2024/04/03 | 1,381 | 1,424 | 1,367 | 1,414 | +3 | +0.2% | 80,800 |
| 2024/04/02 | 1,438 | 1,445 | 1,398 | 1,411 | -27 | -1.9% | 119,800 |
| 2024/04/01 | 1,471 | 1,484 | 1,438 | 1,438 | -7 | -0.5% | 97,800 |
| 2024/03/29 | 1,488 | 1,509 | 1,424 | 1,445 | -42 | -2.8% | 147,900 |
| 2024/03/28 | 1,450 | 1,525 | 1,450 | 1,487 | +35 | +2.4% | 137,000 |
| 2024/03/27 | 1,476 | 1,482 | 1,448 | 1,452 | -30 | -2% | 92,800 |
| 2024/03/26 | 1,414 | 1,483 | 1,393 | 1,482 | +56 | +3.9% | 143,300 |
| 2024/03/25 | 1,372 | 1,450 | 1,372 | 1,426 | +47 | +3.4% | 214,500 |
| 2024/03/22 | 1,386 | 1,386 | 1,343 | 1,379 | -10 | -0.7% | 186,700 |
| 2024/03/21 | 1,430 | 1,445 | 1,380 | 1,389 | -30 | -2.1% | 220,200 |
| 2024/03/19 | 1,445 | 1,463 | 1,406 | 1,419 | -32 | -2.2% | 115,000 |
| 2024/03/18 | 1,461 | 1,502 | 1,445 | 1,451 | +39 | +2.8% | 185,700 |
| 2024/03/15 | 1,469 | 1,469 | 1,398 | 1,412 | -54 | -3.7% | 172,500 |
| 2024/03/14 | 1,416 | 1,507 | 1,415 | 1,466 | +55 | +3.9% | 350,900 |
| 2024/03/13 | 1,469 | 1,496 | 1,355 | 1,411 | -88 | -5.9% | 538,400 |
| 2024/03/12 | 1,387 | 1,650 | 1,381 | 1,499 | +94 | +6.7% | 1,317,200 |
| 2024/03/11 | 1,499 | 1,525 | 1,380 | 1,405 | -35 | -2.4% | 288,000 |
| 2024/03/08 | 1,411 | 1,467 | 1,403 | 1,440 | +20 | +1.4% | 237,700 |
| 2024/03/07 | 1,508 | 1,520 | 1,410 | 1,420 | -80 | -5.3% | 340,400 |
| 2024/03/06 | 1,437 | 1,539 | 1,430 | 1,500 | +121 | +8.8% | 497,200 |
| 2024/03/05 | 1,375 | 1,403 | 1,370 | 1,379 | -26 | -1.9% | 145,700 |
| 2024/03/04 | 1,421 | 1,427 | 1,358 | 1,405 | -9 | -0.6% | 205,700 |
| 2024/03/01 | 1,364 | 1,430 | 1,364 | 1,414 | +43 | +3.1% | 291,300 |
| 2024/02/29 | 1,359 | 1,378 | 1,321 | 1,371 | +8 | +0.6% | 145,800 |
| 2024/02/28 | 1,346 | 1,377 | 1,341 | 1,363 | +29 | +2.2% | 213,900 |
| 2024/02/27 | 1,345 | 1,361 | 1,316 | 1,334 | +19 | +1.4% | 163,500 |
| 2024/02/26 | 1,224 | 1,334 | 1,203 | 1,315 | +92 | +7.5% | 335,000 |
| 2024/02/22 | 1,242 | 1,250 | 1,202 | 1,223 | -18 | -1.5% | 226,700 |
| 2024/02/21 | 1,317 | 1,317 | 1,241 | 1,241 | -57 | -4.4% | 173,500 |
| 2024/02/20 | 1,328 | 1,330 | 1,289 | 1,298 | -14 | -1.1% | 122,000 |
| 2024/02/19 | 1,248 | 1,323 | 1,241 | 1,312 | +75 | +6.1% | 196,400 |
| 2024/02/16 | 1,197 | 1,252 | 1,196 | 1,237 | +42 | +3.5% | 175,900 |
| 2024/02/15 | 1,250 | 1,250 | 1,193 | 1,195 | -59 | -4.7% | 260,500 |
| 2024/02/14 | 1,265 | 1,268 | 1,235 | 1,254 | -29 | -2.3% | 134,500 |
| 2024/02/13 | 1,279 | 1,314 | 1,277 | 1,283 | +5 | +0.4% | 119,800 |
| 2024/02/09 | 1,299 | 1,303 | 1,270 | 1,278 | -22 | -1.7% | 89,200 |
| 2024/02/08 | 1,296 | 1,313 | 1,272 | 1,300 | -8 | -0.6% | 115,000 |
| 2024/02/07 | 1,315 | 1,344 | 1,281 | 1,308 | -35 | -2.6% | 153,700 |
| 2024/02/06 | 1,363 | 1,364 | 1,316 | 1,343 | -28 | -2% | 177,300 |
| 2024/02/05 | 1,314 | 1,388 | 1,288 | 1,371 | +56 | +4.3% | 247,500 |
| 2024/02/02 | 1,276 | 1,337 | 1,265 | 1,315 | +38 | +3% | 236,500 |
| 2024/02/01 | 1,235 | 1,280 | 1,235 | 1,277 | +28 | +2.2% | 161,400 |
151～
200
件表示中 / 1240件
類似銘柄と比較する
現在ご覧いただいている「セルソース」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| セルソース | 111,700円 | -3.0% | -55.9% | 0.45% | 53.06倍 | 3.66倍 |
|
脂肪・血液由来の細胞加工受託など再生医療、変形性ひざ関節症向け軸に不妊治療関連も展開 |
| ミズホメディ | 163,000円 | -5.1% | -21.2% | 4.91% | 10.29倍 | 1.96倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
| 扶桑薬 | 266,000円 | +8.3% | +98.1% | 3.08% | 8.74倍 | 0.60倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
市場注目の銘柄
チャート関連のコラム
